Geneva, May 29 -- International Clinical Trials Registry received information related to the study (KCT0012025) titled 'A phase 4 clinical trial to evaluate the efficacy and safety of "Stillen Tab." versus "Patisren Tab." in patients with acute or chronic gastritis' on May 22.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Richwood Trading Company
Condition:
Diseases of the digestive system
Intervention:
Drug : Subjects will be randomized 1:1 to either the investigational or control group and provided with the investigational product (IP) for 14 (±3) days. Starting ...